Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Virginia Tech researcher receives $1.7 million to study herpes simplex virus

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2 (HSV1 and HSV2).

HSV1 and HSV2 are highly contagious and incurable. The viruses establish latency in sensory and autonomic neurons (nerve cells), from which they can reactivate to cause recurrent disease, affecting more than 250 million people in the U.S. alone, according to Bertke.

HSV1 is typically associated with cold sores, also known as oral herpes, and HSV2 with genital herpes, although either one can be transmitted to either site. In addition to skin lesions and pain, they can cause blinding ocular infection, meningitis, and encephalitis. In fact, HSV1 is one of the leading causes of infectious corneal blindness in the world and, according to World Health Organization estimates, over half a billion people between the ages of 15-49 years have genital infection caused by either HSV1 or HSV2.

Some types of neurons support HSV replication upon entry, while other types naturally inhibit replication, resulting in latency. HSV only reactivates from a portion of the latently infected neurons, causing recurrent disease and viral shedding. In addition, the subtypes of neurons that support these different outcomes of infection are different for HSV1 and HSV2.

“The goal of this project is to figure out how some neurons naturally shut down virus replication initially and what intrinsic inhibitory mechanisms in those neurons shut it down,” Bertke said. “If we can find those mechanisms, we can exploit them to prevent replication in all neurons.”

Previous studies of HSV regulatory mechanisms have relied on whole tissues, cell lines, or embryonic neuronal cultures, which do not permit analysis of neuron type-specific mechanisms.

“How these mechanisms differ between HSV1 and HSV2, leading to different patterns and frequencies of recurrent disease, is grossly understudied,” Bertke said. “Understanding how different types of mature neurons regulate viral infections represents a significant gap in knowledge, one that is of critical importance, since neurons are long-lived terminally differentiated cells not easily replaced in adults.”

Bertke’s research team previously determined that in adult sensory neurons, continuous presence of certain neurotrophic factors maintains HSV in a latent state, and deprivation of these factors selectively induces viral reactivation. With the new five-year grant, the team will build on their work to identify what they call the “latency lock” – the development of a molecule or antiviral that can latch onto the virus and permanently lock it in a latent state incapable of reactivation, in any type of neuron.

“In these studies, we will identify specific neuron signaling pathways that allow the virus to reactivate and determine if there are inhibitors that will prevent the reactivation process,” said Bertke. “If we can put those mechanisms together, we may be able to permanently shut down the virus. Then, we’ll never have recurrent disease or viral shedding, and we’ll never have it spreading to other hosts.”

Other Virginia Tech scholars on the project team include Telvin Harrell, Ph.D. student in the veterinary college’s biomedical and veterinary sciences program and former Multicultural Academic Opportunities Program mentee in the Bertke lab; Poorna Goswami, Ph.D. student in translational biology, medicine, and health; Lindsey Henry, master’s student in public health; and two undergraduate students, Amber Abbott, junior in microbiology, and Dominique Ngo, senior in biology and Spanish. Jack Thompson, senior in biochemistry, helped to develop preliminary data for the project.

Other collaborators on the project include Seth Frietze, assistant professor at the University of Vermont College of Nursing and Health Sciences and co-investigator on the grant, and Anna Cliffe, assistant professor at the University of Virginia School of Medicine.

This is Bertke’s second grant from NINDS this year; the first was a two-year grant awarded in April. She and co-investigator David Davido, associate professor at the University of Kansas, are working to identify the role of an HSV1 protein, ICP0, in latency and reactivation in neurons.

Source:

https://vtnews.vt.edu/articles/2018/10/vetmed-bertke-grant.html

Tagged with:

About author

Related Articles